Results 201 to 210 of about 9,520 (232)

Antimicrobial prescribing guidelines for feedlot cattle

Australian Veterinary Journal, EarlyView.
P Cusack, T Batterham, SW Page, GF Browning, JM Norris   +4 more
wiley   +1 more source

Cytosolic delivery of bacterial metabolites by riboflavin transporters promotes MR1 antigen presentation and MAIT cell recognition

Immunology &Cell Biology, EarlyView.
VitBAg antigen presentation is promoted through a cytosolic pathway that reaches ligand‐receptive MR1 to present to MAIT cells, like the riboflavin transport pathway. Riboflavin solute carrier transporters can promote this MR1 presentation, but they are not essential for this role, suggesting redundant pathways to uptake VitBAg.
Sebastian Cruz‐Gomez, Hui Jing Lim, Brunda Nijagal, Yuting Yang, Nicole Lau, Jeffrey YW Mak, David P Fairlie, Hayley Newton, Mariolina Salio, Jose A Villadangos, Hamish EG McWilliam   +10 more
wiley   +1 more source

Human Immunodeficiency Virus-Human Pegivirus Coinfected Individuals Display Functional Mucosal-Associated Invariant T Cells and Follicular T Cells Irrespective of PD-1 Expression. [PDF]

Viral Immunol
Vimali J, Yong YK, Murugesan A, Govindaraj S, Raju S, Balakrishnan P, Larsson M, Velu V, Shankar EM.   +8 more
europepmc   +1 more source

Mucosal-Associated Invariant T Cells are not susceptible in vitro to SARS-CoV-2 infection but accumulate into the lungs of COVID-19 patients. [PDF]

Virus Res
Huang X, Kantonen J, Nowlan K, Nguyen NA, Jokiranta ST, Kuivanen S, Heikkilä N, Mahzabin S, Kantele A, Vapalahti O, Myllykangas L, Heinonen S, Mäyränpää MI, Strandin T, Kekäläinen E.   +14 more
europepmc   +1 more source

Thymic precursors to the Mucosal-Associated Invariant T cell lineage

, 2016
Godfrey, D., Koay, H. -F, Gherardin, N., Enders, A., Loh, L., Chen, Z., Corbett, A., Eckle, S., Meehan, B., d'Udekem, Y., Konstantinov, I, Lappas, M., Liu, L., Goodnow, C., Fairlie, D., Rossjohn, J., Kedzierska, K., Berzins, S., McCluskey, J., Uldrich, A., Pellicci, D.   +20 more
openaire   +1 more source

Mucosal-Associated Invariant T Cells in Regenerative Medicine

Mucosal-Associated Invariant T Cells in Regenerative Medicine
openaire  

Mucosal-associated invariant T cells in Giant Cell Arteritis

Journal of Autoimmunity, 2021
This study aimed to assess the implication of mucosal-associated invariant T (MAIT) cells in GCA. Blood samples were obtained from 34 GCA patients (before and after 3 months of treatment with glucocorticoids (GC) alone) and compared with 20 controls aged >50 years.
Marion Ciudad, André Ramon, Hélène Greigert   +2 more
exaly   +4 more sources

Development of mucosal‐associated invariant T cells [PDF]

Immunology and Cell Biology, 2018
AbstractMucosal‐associated invariant T (MAIT) cells develop in the thymus and migrate into the periphery to become the largest antigen‐specific αβ T‐cell population in the human immune system. However, the frequency of MAIT cells varies widely between human individuals, and the basis for this is unclear.
Hui-Fern Koay, Dale I Godfrey, Daniel G Pellicci   +2 more
exaly   +4 more sources

Antimicrobial activity of mucosal-associated invariant T cells [PDF]

Nature Immunology, 2010
Mucosal-associated invariant T lymphocytes (MAIT lymphocytes) are characterized by two evolutionarily conserved features: an invariant T cell antigen receptor (TCR) alpha-chain and restriction by the major histocompatibility complex (MHC)-related protein MR1. Here we show that MAIT cells were activated by cells infected with various strains of bacteria
Lionel Le Bourhis, Emmanuel Martin, Virginie Premel   +2 more
exaly   +5 more sources